Overview

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Anzhen Hospital
Treatments:
Calcium heparin
Dalteparin
Enoxaparin
Enoxaparin sodium
Heparin
Heparin, Low-Molecular-Weight
Platelet Aggregation Inhibitors
Ticagrelor
Tinzaparin